Weekly Biotech Catalysts

Every Sunday: the coming week of FDA decision dates, Phase 2 and 3 trial completions and earnings, plus the past week of delays, discontinuations, FDA decisions and new timelines from SEC filings.

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jun 28–Jul 5, 2026)

June 28, 2026 ·

Here’s what’s on the biotech calendar for June 28–July 5: 2 FDA decision dates, 15 trial catalysts, and 0 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date Ticker Drug Indication Type 2026-06-29 UNCY — hyperphosphatemia in patients NDA 2026-06-30 VRDN — patients with TED BLA 📡 Run-up Radar Highlights Stocks entering the […]

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jun 21–Jun 28, 2026)

June 21, 2026 ·

Here’s what’s on the biotech calendar for June 21–June 28: 0 FDA decision dates, 0 trial catalysts, and 0 earnings reports from tracked companies. 📡 Run-up Radar Highlights Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature): UNCY — NDA in 8 days, score 84/100 CELC — NDA in […]

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.